150 related articles for article (PubMed ID: 23420924)
1. Neonatal visual evoked potentials in infants born to mothers prescribed methadone.
McGlone L; Hamilton R; McCulloch DL; Boulton R; Bradnam MS; Weaver LT; Mactier H
Pediatrics; 2013 Mar; 131(3):e857-63. PubMed ID: 23420924
[TBL] [Abstract][Full Text] [Related]
2. Visual evoked potentials in infants exposed to methadone in utero.
McGlone L; Mactier H; Hamilton R; Bradnam MS; Boulton R; Borland W; Hepburn M; McCulloch DL
Arch Dis Child; 2008 Sep; 93(9):784-6. PubMed ID: 18305073
[TBL] [Abstract][Full Text] [Related]
3. Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy.
McGlone L; Hamilton R; McCulloch DL; MacKinnon JR; Bradnam M; Mactier H
Br J Ophthalmol; 2014 Feb; 98(2):238-45. PubMed ID: 24246372
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy.
Hamilton R; McGlone L; MacKinnon JR; Russell HC; Bradnam MS; Mactier H
Br J Ophthalmol; 2010 Jun; 94(6):696-700. PubMed ID: 20410537
[TBL] [Abstract][Full Text] [Related]
5. In utero drug and alcohol exposure in infants born to mothers prescribed maintenance methadone.
McGlone L; Mactier H; Hassan H; Cooper G
Arch Dis Child Fetal Neonatal Ed; 2013 Nov; 98(6):F542-4. PubMed ID: 23836138
[TBL] [Abstract][Full Text] [Related]
6. Drug misuse in pregnancy: losing sight of the baby?
McGlone L; Mactier H; Weaver LT
Arch Dis Child; 2009 Sep; 94(9):708-12. PubMed ID: 19329443
[TBL] [Abstract][Full Text] [Related]
7. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
8. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
Whitham JN; Spurrier NJ; Sawyer MG; Baghurst PA; Taplin JE; White JM; Gordon AL
Neurotoxicol Teratol; 2010; 32(2):280-8. PubMed ID: 19751825
[TBL] [Abstract][Full Text] [Related]
9. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.
Choo RE; Huestis MA; Schroeder JR; Shin AS; Jones HE
Drug Alcohol Depend; 2004 Sep; 75(3):253-60. PubMed ID: 15283946
[TBL] [Abstract][Full Text] [Related]
10. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants.
Miles J; Sugumar K; Macrory F; Sims DG; D'Souza SW
Child Care Health Dev; 2007 Mar; 33(2):206-12. PubMed ID: 17291325
[TBL] [Abstract][Full Text] [Related]
11. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
Lewis AJ; Galbally M; Opie G; Buist A
Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
[TBL] [Abstract][Full Text] [Related]
12. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
13. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
14. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
[TBL] [Abstract][Full Text] [Related]
15. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
16. Maternal methadone dose during pregnancy and infant clinical outcome.
Wouldes TA; Woodward LJ
Neurotoxicol Teratol; 2010; 32(3):406-13. PubMed ID: 20102736
[TBL] [Abstract][Full Text] [Related]
17. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
18. Infants of opioid-dependent mothers: neurodevelopment at six months.
McGlone L; Mactier H
Early Hum Dev; 2015 Jan; 91(1):19-21. PubMed ID: 25460252
[TBL] [Abstract][Full Text] [Related]
19. Impaired vision in children prenatally exposed to methadone: an observational cohort study.
Hamilton R; Mulvihill A; Butler L; Chow A; Irving E; McCulloch DL; McNeil A; Michael K; Spowart KM; Waterson-Wilson J; Mactier H
Eye (Lond); 2024 Jan; 38(1):118-126. PubMed ID: 37402864
[TBL] [Abstract][Full Text] [Related]
20. Visual evoked potentials in infants of diabetic mothers: relations to clinical and metabolic status during pregnancy and delivery.
Brinciotti M; Matricardi M; Colatrella A; Torcia F; Fallucca F; Napoli A
Clin Neurophysiol; 2009 Mar; 120(3):563-8. PubMed ID: 19181572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
